Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Amiodarone in Atrial Fibrillation Associated With Severe Sepsis or Septic Shock

NCT02668432 is registered in ClinicalTrials.gov with The University of Texas Health Science Center at San Antonio as lead sponsor.

NCT NCT02668432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02668432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Amiodarone in Atrial Fibrillation Associated With Severe Sepsis or Septic Shock
Lead sponsor
The University of Texas Health Science Center at San Antonio
Phase
Phase 4
Overall status
Terminated
Start date
May 31, 2016
Completion date
September 20, 2018
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

new onset atrial fibrillation, septic shock, severe sepsis